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1. Introduction
  Apolipoprotein B (apo B) is an important protein 
subunit contributing to the formation of very low (VLDL), 
intermediate (ILDL), low density lipoprotein (LDL) particles, 
and is responsible for clearance of LDL in blood. Apart from 
this, it works as ligand of LDL receptors and contributes 
to cellular uptake of cholesterol[1]. Recently, restriction 
fragment length polymorphism was observed in several 
typical sites of gene region coding aop B, and Xba栺
polymorphism as a kind of silent mutation at Thr2488, which 
is correlated to serum lipid levels and the incidence of 
coronary heart disease[2-4]. Li ethnic group is the smallest 
ethnic group among 55 minority ethnic groups in China. Till 
now, less information is known about Xba 栺 polymorphism 
of apoB gene and its association with lipid profiles in Li 
ethnic group, and this study is aimed to elucidate it.
2. Materials and methods
2.1. Study population
   This study protocol was approved by the ethnic committee 
of the people’s hospital of Sanya, China. All participants 
involved in the study have signed consent form. A total of 
151 (93 men and 58 women, aged 20-84 years) unrelated 
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healthy Li people were selected randomly by cluster 
sampling as study group. A total of 200 (113 men and 87 
women, aged 22-83 years) unrelated healthy Han people 
were recruited as control group. All participants reside in 
Changjiang or Lingshui counties of Hainan province without 
special dietary habits. They were screened on the basis 
of no history in heart, nervous and hereditary diseases, 
hyperlipemia secondary to diabetes, hyperthyroidism, 
chronic hepatic or nephritic diseases and other diseases 
affecting lipid metabolism.
2.2.  Blood sample collection and process
  Whole blood (10 mL) was collected from forearms vein in a 
sitting position post 12 h’s fasting. A part of sample (5 mL) 
without anticoagulation was used to isolated serum within 
4 h and stored at -20 曟 for lipid and lipoprotein assay. The 
remaining sample was transferred into EDTA-containing 
tubes for genotyping. Genomic DNA was extracted according 
to standard protocols[5].
2.3. Lipid and lipoprotein determination
  Blood total cholesterol (TC), total triglyceride (TG), high 
density lipoprotein cholesterol (HDL-C) and low density 
lipoprotein cholesterol (LDL-C) were assessed by enzymatic 
methods with commercial available kits. Apoprotein A 
(apo A) and apoprotein B (apo B) were determined by 
immunoturbidimetric immunoassay, using a commercial kit. 
All the determinations were completed with an autonomic 
biochemistry analyzer (Type LX-20; Backmen Ltd., USA) 
in the Clinical Science Experiment Center of the Affiliated 
Hospital, Hainan Medical College.
2.4. Genetic analysis
  Xba 栺polymorphism of apo B gene was determined 
by PCR amplification in a total volume of 50 毺L, 
composed of 5 毺L template DNA, 4 毺L primers, 5 毺
L 10暳GC buffer, 4 毺L dNTPs, 0.2 毺L Taq polymerase, 
and 31.8 毺L double distilled water. The primers 
were  5 ’-GGAGACTATTCAGAAGCTAA-3 ’and 5 ’-
GAAGAGCCTGAAGACTGACT-3’[6,7]. Cycling was performed 
with conditions consist of an initial melting temperature of 
95 曟 for 5 min, followed by 30 cycles of melting (95 曟, 60 s), 
annealing (50 曟, 50 s), extension (72 曟, 50 s) with sequent 
extension for 7 min. The product (30 毺L) was subject to Xba 
栺 restriction enzymatic analysis according to manufacture’s 
instruction, and then isolated by electrophoresis with fine 
resolution agarose gel for 30 min, and visualized under UV 
lamp. X-/X- genotype produced a 710 bp fragment, X-/X+ 
genotype produced 710 bp, 277 bp and 433 bp fragments, 
while X+/X+ genotype yielded 277 bp and 433 bp fragments[8]. 
2.5. Statistical analysis
  Statistical analysis was carried out using the SPSS statistical 
package version 13. Values were present with mean暲SD, 
or percentage. Allelic frequency was calculated by gene 
counting, Hardy-Weinberg equilibrium was employed to 
compare observed and expected genotypes. Student’s test 
and one-way ANOVA were used to analyze differences of 
serum lipid and lipoprotein levels among genotypes and 
alleles. The 氈
2 test was used to compare genotypic and 
allelic frequencies between study and control groups. The 




3.1. Apo B genotyping
  Products of PCR amplification and Xba 栺 restriction 
enzyme digested product were shown in Figure 1 and 2; 
those were in accordance with sequencing results performed 
by TIANGEN BIOTECH (BEIJING) co., Ltd.
1                 2                3              4                5              6              7
Figure 1. Product of PCR amplification of apoB gene. 
No 1-6 are from samples, No 7 is from marker.
1              2              3            4              5             6              7             8           9
Figure 2. Xba 栺restriction enzyme digested product of apoB gene. 
No 2 is for X-/X+ genotype, No 9 is marker, the left is for X-/X- 
genotype.
Yue-Li Liu et al./Asian Pacific Journal of Tropical Medicine (2014)63-64 65
3.2. Genotypic and allelic frequency distribution of Xba栺
sites in apoB gene
  Genotypes of apoB Xba 栺of Li (氈
2=1.06, P=0.60) and Han 
people were in Hardy-Weinberg equilibrium (氈
2=0.00, 
P=1.00) (Table 1). Table 2 shows the distributions of allele 
frequency and genotype of Xba 栺sites in apoB gene in 
study and control groups. The heterozygotes X-/X+ genotype 
frequency in Li people was significantly higher than Han 
people (氈
2=5.61, P=0.02), while X+/X+ genotype wasn’t 
detected in both Li and Han people. X+ allele was more 
frequent in Li people than Han people (氈
2=5.38, P=0.02).
Table 1
Hardy-Weinberg equilibrium of genotypes of Xba 栺polymorphism in 
apoB gene in Li and Han people.
Group Frequency of genotypes (n, %)
X
+/ X- X-/ X- X+/ X+
Li people Actual frequency 138     13        0
Theoretical frequency 16.77 133.71 0.52
Han people Actual frequency   10   190        0
Theoretical frequency   9.75  190.12 0.12
Table 2
Genotypes and allele frequencies of Xba 栺 polymorphism in apoB 
gene in Li and Han people.
Group Frequency of genotypes (n, %) Frequency of allele (n, %)
X
+/ X-   X-/ X-  X+/ X+ X+  X-
Li people 18(0.12)﹡ 133(0.89) 0(0.00) 18(0.06)﹡ 284(0.94)
Han people 10(0.05) 190(0.95) 0(0.00) 10(0.02) 390(0.97)
﹡ P<0.05 , as compared to Han people.
3.3.Serum lipids levels and its correlation to Xba栺
polymorphism of apoB gene 
  As shown in Table 3 and 4, serum TC and LDL-C levels in 
Li people were lower (P<0.05 P<0.01), while HDL-C level 
was significantly higher compared to Han people (P<0.01). 
HDL-C level was reduced while LDL-C level was enhanced 
(P<0.05), and serum levels of TC, TG, apoA, apoB were 
identical in X-/X+ genotype carriers compared to X-/X- 
carriers both in Li and Han people. 
4. Discussion
  It is reported that frequencies of apoB gene polymorphism 
vary among different ethnic groups[9], and there is a kind of 
polymorphism existed in apoB gene Xba 栺 restriction sites, 
in which allele C is replaced by T at the 2488 nucleotides 
site in the exon 26; It causes a silent mutation in threonine 
residue[2]. Indeed, there are some reports shown that X+ 
allele carriers have a higher serum LDL than X- allele 
carriers[3,10]. Although X+/X+ genotype is rare both in Li 
and Han population, in present study, apoB gene Xba 栺
polymorphism was detected in Li ethnic group, and this is 
in concordance with previous study performed by Tsunoda 
K in the Mongolian Buryat[4]. However, X+ allele frequencies 
were 0.059 in Li population, higher than Han population, 
and similar to that in the Mongolian Buryat. But it was 
dramatically distinct to Mexican patients with coronary 
artery disease[11]. That is the reason that we need to study 
Xba 栺 polymorphism in apoB gene in different population.
  Our data indicated that serum level of TC and LDL-C were 
lower, while level of HDL-C was enhanced in Li population 
compared to those in Han population, and this may be 
related to their dietary habits. As previously reported 
by Rantala et al[12], ApoB gene Xba 栺 polymorphism is 
correlated to response of serum TC and LDL-C during 
baseline, low fat, high fat and switch back diet. Especially, 
X
-/X- genotype carriers had the greatest enhancement and 
Table 3
Comparison of serum lipids and lipoproteins between Li and Han people.
Group TG TC HDL-C LDL-C apo A apo B
Li people 1.31暲0.83 5.13暲1.13﹡ 1.62暲0.32﹡﹡ 3.07暲0.95﹡﹡ 1.36暲0.18 0.87暲0.36
Han people 1.48暲0.76 5.47暲0.82 1.42暲0.30 3.38暲0.66 1.22暲0.27 0.90暲0.08
﹡ P<0.05 , ﹡﹡ P<0.01 as compared to Han people.
Table 4
Serum lipid and lipoprotein concentration according to Xba 栺 polymorphism in apoB gene in Li and Han people.
Group    n TC (mmol/L) TG (mmol/L) HDL-C (mmol/L) LDL-C(mmol/L) apo A (g/L) apo B (g/L)
Li people X+/ X-     18 5.13暲0.93 1.49暲0.77 1.49暲0.27﹡ 3.42暲0.96﹡ 1.34暲0.15 0.93暲0.37
X
-/X-  133 5.13暲1.15 1.29暲0.86 1.67暲0.32 2.94暲0.95 1.36暲0.19 0.87暲0.36
Han people X+/ X-   10 5.49 暲0.98 1.51 暲0.84 1.32暲0.31﹡ 3.51暲0.93﹡ 1.15 暲0.26 0.93暲0.29
X
-/X- 190 5.45 暲0.94 1.46 暲0.73 1.45 暲0.33 3.24暲0.89 1.27 暲0.24 0.88 暲0.36
﹡ P<0.05 , compared to X-/X- genotype in the same group.
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shrink in their serum TC and LDL-C when they were given 
high fat and low fat diet respectively, whereas subjects 
carrying X-/X- genotype were more susceptible response to 
diet than subjects with X+/X-  and X+/X+ genotype. Notably, 
most Li people reside in rural area in Hainan province, 
living mainly with vegetable diet. High frequency of X-/
X
- genotype and less dietary lipid intake may explain their 
greater response to diet and result in lower serum TC and 
LDL-C in Li people.
  X-/X+ genotype carriers have suppressed HDL-C and 
increased LDL-C levels both in Li and Han population. 
This is in concordance with previous study completed by 
Hu et al[3], but inconsistent from study performed by Han 
et al[10]. According to Han T’s study, subjects with X-/X+ 
genotype had a higher serum level of TC, LDL-C and apoB, 
and X+ allele was characterized with higher TC and LDL-C. 
Different sample size and various genetic backgrounds may 
be responsible for the inconsistence. 
  X+ allele is known to be associated with coronary heart 
disease and dyslipidemia[11,13]. Coronary heart disease 
is the leading cause of death in developed country, and 
hypercholesterolemia is the key risk factor for coronary 
heart disease. Reduction of cholesterol intake and low fat 
diet are principal treatment for hypercholesterolemia[14-
16]. Different genotype carriers respond differently to diet, 
and have distinct susceptivity of dyslipidemia and coronary 
heart disease; personalized treatment should be applied to 
patients according to their genetic background.
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